Data Science in the News

Measuring failure risk and resiliency in AI/ML models

The widespread use of artificial intelligence (AI) and machine learning (ML) reveals not only the technology’s potential but also its pitfalls, such as how likely these models are to be inaccurate. AI/ML models can fail in unexpected ways even when not under attack, and they can fail in scenarios differently from how humans perform. Knowing when and why failure occurs can prevent costly...

Measuring attack vulnerability in AI/ML models

LLNL is advancing the safety of AI/ML models in materials design, bioresilience, cyber security, stockpile surveillance, and many other areas. A key line of inquiry is model robustness, or how well it defends against adversarial attacks. A paper accepted to the renowned 2024 International Conference on Machine Learning explores this issue in detail. In “Adversarial Robustness Limits via...

Evaluating trust and safety of large language models

Accepted to the 2024 International Conference on Machine Learning, two Livermore papers examined trustworthiness—how a model uses data and makes decisions—of large language models, or LLMs. In “TrustLLM: Trustworthiness in Large Language Models,” Bhavya Kailkhura and collaborators from universities and research organizations around the world developed a comprehensive trustworthiness...

ISCP projects make machine learning advantages tangible

Data science tools are not only rapidly taking hold across disciplines, they are constantly evolving. The applications, services, and techniques one cohort of scientists and engineers may have learned could be out of date by the next cohort, especially as machine learning (ML) and artificial intelligence (AI) tools become commonplace. To keep employees abreast of the latest tools, two data...

LLNL and BridgeBio announce trials for supercomputing-discovered cancer drug

In a substantial milestone for supercomputing-aided drug design, LLNL and BridgeBio Oncology Therapeutics (BridgeBio) today announced clinical trials have begun for a first-in-class medication that targets specific genetic mutations implicated in many types of cancer. The development of the new drug—BBO-8520—is the result of collaboration among LLNL, BridgeBio and the National Cancer...

Welcome new DSI team members

When Data Science Institute (DSI) director Brian Giera and deputy director Cindy Gonzales began planning activities for fiscal year 2024 and beyond, they immediately realized that LLNL’s growth in data science and artificial intelligence (AI)/machine learning (ML) research requires corresponding growth in the DSI’s efforts. “Our field is booming,” Giera states. “The Lab has a stake in the...

LLNL’s Kailkhura elevated to IEEE senior member

IEEE, the world’s largest technical professional organization, has elevated LLNL research staff member Bhavya Kailkhura to the grade of senior member within the organization. IEEE has more than 427,000 members in more than 190 countries, including engineers, scientists and allied professionals in the electrical and computer sciences, engineering and related disciplines. Just 10% of IEEE’s...

Explainable artificial intelligence can enhance scientific workflows

As ML and AI tools become more widespread, a team of researchers in LLNL’s Computing and Physical and Life Sciences directorates are trying to provide a reasonable starting place for scientists who want to apply ML/AI, but don’t have the appropriate background. The team’s work grew out of a Laboratory Directed Research and Development project on feedstock materials optimization, which led to...

Cognitive simulation supercharges scientific research

Computer modeling has been essential to scientific research for more than half a century—since the advent of computers sufficiently powerful to handle modeling’s computational load. Models simulate natural phenomena to aid scientists in understanding their underlying principles. Yet, while the most complex models running on supercomputers may contain millions of lines of code and generate...

LLNL researchers win HPCwire award for applying cognitive simulation to ICF

The high performance computing publication HPCwire announced LLNL as the winner of its Editor’s Choice award for Best Use of HPC in Energy for applying cognitive simulation (CogSim) methods to inertial confinement fusion (ICF) research. The award was presented at the largest supercomputing conference in the world: the 2022 International Conference for High Performance Computing, Networking...

Panel discussion spotlights COVID-19 R&D

The DSI’s career panel series continued on June 28 to highlight some of LLNL’s COVID-19 research projects. Three data scientists—Emilia Grzesiak, Derek Jones, and Priyadip Ray—joined moderator and data scientist Stewart He to talk about their work in drug screening, protein–drug compounds, antibody–antigen sequence analysis, and risk factor identification. He, who earned a PhD in Computer...

UC Merced students work with LLNL mentors on potential new drugs to combat COVID-19

Students from the University of California, Merced worked with mentors at LLNL to identify drug compounds that could be used to treat COVID-19 during a two-week Data Science Challenge (DSC) that concluded on June 6. For the first time in the DSC series since the COVID-19 pandemic began in 2020, Lab mentors visited the college campus to provide in-person guidance for five teams of UC Merced...

Assured and robust…or bust

The consequences of a machine learning (ML) error that presents irrelevant advertisements to a group of social media users may seem relatively minor. However, this opacity, combined with the fact that ML systems are nascent and imperfect, makes trusting their accuracy difficult in mission-critical situations, such as recognizing life-or-death risks to military personnel or advancing materials...

LLNL’s Brase discusses advances by ATOM in accelerating drug discovery pipeline

The private-public Accelerating Therapeutic Opportunities in Medicine (ATOM) consortium is showing “significant” progress in demonstrating that HPC and M) tools can speed up the drug discovery process, said Jim Brase, ATOM co-lead and LLNL’s deputy associate director for data science. The consortium currently boasts more than a dozen member organizations, including national laboratories...

CASC team wins best paper at visualization symposium

A research team from LLNL’s Center for Applied Scientific Computing won Best Paper at the 15th IEEE Pacific Visualization Symposium (PacificVis), which was held virtually on April 11–14. Computer scientists Harsh Bhatia, Peer-Timo Bremer, and Peter Lindstrom collaborated with University of Utah colleagues Duong Hoang, Nate Morrical, and Valerio Pascucci on “AMM: Adaptive Multilinear Meshes.”...

Kevin McLoughlin applies computational biology to complex problems

Kevin McLoughlin has always been fascinated by the intersection of computing and biology. His LLNL career encompasses award-winning microbial detection technology, a COVID-19 antiviral drug design pipeline, and work with the ATOM consortium. The appeal for him in these projects lies at the intersection of computing and biology. “I love finding ways to visualize data that reveal relationships...

Accelerating the path to precision medicine

LLNL joined the Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI) consortium in 2018. The national, multiyear, multidisciplinary effort, led by the University of California at San Francisco in collaboration with Lawrence Berkeley and Argonne national laboratories and other leading research organizations and universities, combines neuroimaging, blood-based...

Machine learning model finds COVID-19 risks for cancer patients

A new study by researchers at LLNL and the University of California, San Francisco, looks to identify cancer-related risks for poor outcomes from COVID-19. Analyzing one of the largest databases of patients with cancer and COVID-19, the team found previously unreported links between a rare type of cancer—as well as two cancer treatment-related drugs—and an increased risk of hospitalization...

Winter hackathon meets WiDS datathon

Sponsored by the DSI, LLNL’s winter hackathon took place on February 16–17. Hackathons are 24-hour events that encourage collaborative programming and creative problem solving. In addition to traditional hacking, the hackathon included a special datathon competition in anticipation of the Women in Data Science (WiDS) conference on March 7. Hackathon and datathon participants presented their...

LLNL team models COVID-19 disease progression and identifies risk factors

An LLNL team has developed a comprehensive dynamic model of COVID-19 disease progression in hospitalized patients, finding that risk factors for complications from the disease are dependent on the patient’s disease state. Using a machine learning algorithm on a dataset of electronic health records from more than 1,300 hospitalized COVID-19 patients with ProMedica — the largest health care...